VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Transurban Group vs Thermo Fisher Scientific Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Transurban Group
TCL · Australian Securities Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Transurban Group's moat claims, evidence, and risks.
View TCL analysisThermo Fisher Scientific Inc.
TMO · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Thermo Fisher Scientific Inc.'s moat claims, evidence, and risks.
View TMO analysisComparison highlights
- Moat score gap: Transurban Group leads (91 / 100 vs 64 / 100 for Thermo Fisher Scientific Inc.).
- Segment focus: Transurban Group has 4 segments (49.5% in Sydney toll roads); Thermo Fisher Scientific Inc. has 4 segments (53.6% in Laboratory Products and Biopharma Services).
- Primary market structure: Quasi-Monopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Transurban Group has 3 moat types across 3 domains; Thermo Fisher Scientific Inc. has 8 across 3.
Primary market context
Transurban Group
Sydney toll roads
Urban toll-road concessions (Sydney)
Sydney, New South Wales, Australia
Motorists and commercial fleet operators
Concessionaire / operator and developer
49.5%
Thermo Fisher Scientific Inc.
Laboratory Products and Biopharma Services
Laboratory supplies distribution/market channel plus outsourced biopharma services (CDMO/CRO)
Global
Pharma & biotech; academic/government labs; industrial and clinical laboratories
Distributor/market channel and outsourced services provider
53.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Transurban Group strengths
Thermo Fisher Scientific Inc. strengths
Segment mix
Transurban Group segments
Full profile >Sydney toll roads
Quasi-Monopoly
Melbourne toll roads
Quasi-Monopoly
Brisbane toll roads
Quasi-Monopoly
North America managed lanes and concessions
Quasi-Monopoly
Thermo Fisher Scientific Inc. segments
Full profile >Life Sciences Solutions
Oligopoly
Analytical Instruments
Oligopoly
Specialty Diagnostics
Oligopoly
Laboratory Products and Biopharma Services
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.